STAAR Surgical STAA Stock
STAAR Surgical Price Chart
STAAR Surgical STAA Financial and Trading Overview
| STAAR Surgical stock price | 26.39 USD |
| Previous Close | 26.78 USD |
| Open | 26.81 USD |
| Bid | 16.92 USD x 200 |
| Ask | 29.05 USD x 200 |
| Day's Range | 26.16 - 26.9 USD |
| 52 Week Range | 15.59 - 35.87 USD |
| Volume | 370.14K USD |
| Avg. Volume | 875.54K USD |
| Market Cap | 1.32B USD |
| Beta (5Y Monthly) | 1.2 |
| PE Ratio (TTM) | 2639 |
| EPS (TTM) | 0.01 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.56 USD |
STAA Valuation Measures
| Enterprise Value | 1.17B USD |
| Trailing P/E | 2639 |
| Forward P/E | 23.689407 |
| PEG Ratio (5 yr expected) | 0.76 |
| Price/Sales (ttm) | 4.035794 |
| Price/Book (mrq) | 3.5224237 |
| Enterprise Value/Revenue | 3.569 |
| Enterprise Value/EBITDA | 37.51 |
Trading Information
STAAR Surgical Stock Price History
| Beta (5Y Monthly) | 1.2 |
| 52-Week Change | 0.26% |
| S&P500 52-Week Change | 12.28% |
| 52 Week High | 35.87 USD |
| 52 Week Low | 15.59 USD |
| 50-Day Moving Average | 22.97 USD |
| 200-Day Moving Average | 23.9 USD |
STAA Share Statistics
| Avg. Volume (3 month) | 875.54K USD |
| Avg. Daily Volume (10-Days) | 1.04M USD |
| Shares Outstanding | 50.2M |
| Float | 26.18M |
| Short Ratio | 6.17 |
| % Held by Insiders | 0.85% |
| % Held by Institutions | 110.62% |
| Shares Short | 3.65M |
| Short % of Float | 15.15% |
| Short % of Shares Outstanding | 7.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 2, 2026 |
| Most Recent Quarter (mrq) | October 2, 2026 |
| Next Fiscal Year End | January 2, 2027 |
Profitability
| Profit Margin | 0.16% |
| Operating Margin (ttm) | 6.79% |
| Gross Margin | 73.55% |
| EBITDA Margin | 9.51% |
Management Effectiveness
| Return on Assets (ttm) | 2.95% |
| Return on Equity (ttm) | 0.14% |
Income Statement
| Revenue (ttm) | 328.27M USD |
| Revenue Per Share (ttm) | 6.55 USD |
| Quarterly Revenue Growth (yoy) | -12.00000000000000000000000000000000% |
| Gross Profit (ttm) | 241.46M USD |
| EBITDA | 31.24M USD |
| Net Income Avi to Common (ttm) | 530K USD |
| Diluted EPS (ttm) | 0.01 |
| Quarterly Earnings Growth (yoy) | -37.20% |
Balance Sheet
| Total Cash (mrq) | 206.41M USD |
| Total Cash Per Share (mrq) | 4.11 USD |
| Total Debt (mrq) | 33.64M USD |
| Total Debt/Equity (mrq) | 8.95 USD |
| Current Ratio (mrq) | 4.679 |
| Book Value Per Share (mrq) | 7.492 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 21.4M USD |
| Levered Free Cash Flow (ttm) | 41.75M USD |
Profile of STAAR Surgical
| Country | United States |
| State | CA |
| City | Lake Forest |
| Address | 25510 Commercentre Drive |
| ZIP | 92630 |
| Phone | 626 303 7902 |
| Website | https://www.staar.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 921 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Q&A For STAAR Surgical Stock
What is a current STAA stock price?
STAAR Surgical STAA stock price today per share is 26.39 USD.
How to purchase STAAR Surgical stock?
You can buy STAA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for STAAR Surgical?
The stock symbol or ticker of STAAR Surgical is STAA.
Which industry does the STAAR Surgical company belong to?
The STAAR Surgical industry is Medical Instruments & Supplies.
How many shares does STAAR Surgical have in circulation?
The max supply of STAAR Surgical shares is 50.2M.
What is STAAR Surgical Price to Earnings Ratio (PE Ratio)?
STAAR Surgical PE Ratio is 2639.00000000 now.
What was STAAR Surgical earnings per share over the trailing 12 months (TTM)?
STAAR Surgical EPS is 0.01 USD over the trailing 12 months.
Which sector does the STAAR Surgical company belong to?
The STAAR Surgical sector is Healthcare.
STAAR Surgical STAA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
1937.83 USD — |
-1.05
|
— — | 1915.46 USD — | 1955.74 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31061.46 USD — |
-0.9
|
— — | 30735.41 USD — | 31415.87 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
3748.08 USD — |
-0.7
|
— — | 3701.51 USD — | 3782.39 USD — | — - | — — |
